GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General Manager
LAS VEGAS, NV / ACCESSWIRE / September 8, 2015 / GrowBLOX Sciences, Inc., (OTCQB: GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today that former Nevada State Senator Sandra Tiffany has joined GBLX as General Manager of GB Sciences Nevada LLC.
Ms. Tiffany comes to GrowBLOX Sciences as a former Nevada State Senator. During her 14 years in the legislature, she held a number of leadership roles and authored key “game changing” legislation. She has been honored in her community and served on a number of boards and non-profit advisory boards. Ms. Tiffany was in office when Nevada voters approved the “Medical Marijuana Act.”
Ms. Tiffany’s entrepreneurial business experience is also remarkable. Before the age of 30, she established her first company, Computer Methods Inc., in which Ms. Tiffany developed and marketed a system for nuclear medicine image processing. She then parlayed that success by joining Intergraph, a computer-aided design and engineering Fortune 500 firm. During Ms. Tiffany’s 35 years of business experience, she created and managed her own companies that vary from an Internet Café to Government Affairs.
For the last eleven years, Ms. Tiffany has been involved in the payment processing area. Through this valuable banking-related experience, she has developed a large client list and built extensive relationships with local and national financial communities.
Craig Ellins, Chief Executive Officer of GrowBLOX Sciences, stated, “We expect former Senator Tiffany to play a key role as we move GrowBLOX Sciences from the developmental stage to one of commercial success. We believe that the important development of true medicine will be based on our advanced technology and superior products.”
Sandra Tiffany, General Manager of GrowBLOX Sciences, stated, “I am excited to join GrowBLOX Sciences, having long admired their commitment to the careful scientific study of the cannabis plant and by the opportunity to work with my longtime friend Craig Ellins.”
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc. (GBLX) is a biopharmaceutical research and development company focused on creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. The Company has leading technology and cannabis industry processes, with a “big” data-driven clinical research and development loop to bring relief to patients in communities across the country. Through our GBS PR subsidiary, we are developing and globally distributing our GrowBLOX(TM) suite of cultivation and growing chambers. To learn more about GrowBLOX Sciences, Inc., go to: https://growblox.com.
Forward-Looking Statements
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Note: Although the Company’s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as presently constituted.
GrowBLOX is a registered trademark of GrowBLOX Sciences, Inc.
Contact Information
Corporate:
GrowBLOX Sciences, Inc.
6450 Cameron Street, Suite 110A
Las Vegas, NV 89118
866-721-0297
Craig Ellins, CEO
Andrea Small Howard, Chief Science Officer
craig@gbsciences.com
andrea@gbsciences.com
https://growblox.com
Investors:
Hayden IR
hart@haydenir.com
917-658-7878
SOURCE: GrowBLOX Sciences, Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
